azomycin has been researched along with iodoazomycin arabinoside in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (64.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, JD; Golberg, L; Mannan, RH; McEwan, AJ; Mercer, JR; Parliament, MB; Urtasun, RC; Wiebe, LI | 1 |
| Chapman, JD; Roa, WH | 1 |
| Chapman, JD; Lee, J; Mannan, RH; Mercer, JR; Somayaji, VV; Wiebe, LI | 1 |
| al-Arafaj, A; Hutchison, K; Mannan, RH; McEwan, AJ; Mercer, J; Ryan, EA; Wiebe, LI | 1 |
| Chapman, JD; Golberg, LE; Groshar, D; Hoskinson, M; Mannan, RH; McEwan, AJ; Mercer, JR; Parliament, MB; Urtasun, RC; Wiebe, LI | 1 |
| Chapman, JD; Mannan, RH; McEwan, AJ; McPhee, MS; Mercer, JR; Moore, RB; Wiebe, LI | 1 |
| Biskupiak, JE; Krohn, KA | 1 |
| Chapman, JD; Coia, LR; Engelhardt, EL; Fenning, MC; Schneider, RF; Stobbe, CC | 1 |
| Chapman, JD; Mannan, RH; McEwan, AJ; Mercer, JR; Morin, C; Parliament, MB; Urtasun, RC; Wiebe, LI | 1 |
| Stypinski, D; Wiebe, LI | 1 |
| Gordon, I; Lythgoe, MF; McEwan, AJ; Wiebe, LI; Williams, SR | 1 |
| Mercer, JR; Stypinski, D; Wiebe, LI | 1 |
| Busza, AL; Gadian, DG; Gordon, I; Lythgoe, MF; McEwan, AJ; Wiebe, L; Williams, SR | 1 |
| McEwan, AJ; Mercer, JR; Schmidt, RP; Stypinski, D; Tam, YK; Wiebe, LI | 1 |
| Critchley, M; Maltby, P; McEwan, AJ; O'Driscoll, K; Vinjamuri, S; Wiebe, LI | 1 |
| McEwan, AJ; Mercer, JR; Stypinski, D; Tam, YK; Wiebe, LI | 1 |
| Kumar, P; Lee, HC; McEwan, AJ; Mercer, JR; Wiebe, LI | 1 |
| McEwan, AJ; McQuarrie, SA; Mercer, JR; Stypinski, D; Tam, YK; Wiebe, LI | 1 |
| Beiki, D; Kumar, P; Ohkura, K; Seki, K; Wiebe, LI | 1 |
| Kumar, P; McEwan, AJ; Naimi, E; Wiebe, LI | 1 |
| Kumar, P; McEwan, AJ; McQuarrie, SA; Wiebe, LI; Zhou, A | 1 |
| Cheeseman, C; Khlebnikov, V; Kumar, P; Liang, H; Shustov, G; Wiebe, LI; Yang, XH; Zheng, W | 1 |
| McEwan, AJ; Mercer, JR; Wiebe, LI | 1 |
| Kumar, P; Narain, R; Quan, S; Wang, Y; Zhou, A | 1 |
| Cook, GJ; Fong, KW; Goh, V; Tan, T; Wee, J; Yip, C | 1 |
2 review(s) available for azomycin and iodoazomycin arabinoside
| Article | Year |
|---|---|
Pharmacokinetics of SPECT radiopharmaceuticals for imaging hypoxic tissues.
Topics: Animals; Cell Hypoxia; Humans; Iodine Radioisotopes; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon | 1996 |
Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging.
Topics: Biomarkers, Tumor; Carcinoma; Cell Hypoxia; Coordination Complexes; Humans; Magnetic Resonance Imaging; Molecular Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nitroimidazoles; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Prognosis; Thiosemicarbazones; Tomography, Emission-Computed, Single-Photon | 2016 |
1 trial(s) available for azomycin and iodoazomycin arabinoside
| Article | Year |
|---|---|
A rapid and simple assay to determine the blood and urine concentrations of 1-(5-[123/125I]iodo-5-deoxyarabinofuranosyl)-2-nitroimidazole, a hypoxic cell marker.
Topics: Biomarkers; Calibration; Cell Hypoxia; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Iodine Radioisotopes; Nitroimidazoles; Reference Standards; Spectrophotometry, Ultraviolet | 1998 |
22 other study(ies) available for azomycin and iodoazomycin arabinoside
| Article | Year |
|---|---|
Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.
Topics: Adult; Aged; Carcinoma, Small Cell; Female; Half-Life; Humans; Hypoxia; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Neoplasms; Nitroimidazoles; Tomography, Emission-Computed | 1992 |
Killing of EMT-6 cells by decays from isotopes incorporated on sensitizer adducts.
Topics: Animals; Cell Death; Cell Hypoxia; Cell Survival; Cobalt Radioisotopes; Gamma Rays; Iodine Radioisotopes; Kinetics; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors; Tritium; Tumor Cells, Cultured | 1992 |
Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia.
Topics: Animals; Cell Hypoxia; Iodine Radioisotopes; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Tissue Distribution | 1991 |
An evaluation of iodine-123 iodoazomycinarabinoside as a marker of localized tissue hypoxia in patients with diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Gas Monitoring, Transcutaneous; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Foot; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Nitroimidazoles; Peripheral Vascular Diseases; Radionuclide Imaging | 1994 |
Imaging tumor hypoxia and tumor perfusion.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Glioblastoma; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Nitroimidazoles; Organotechnetium Compounds; Oximes; Sarcoma; Soft Tissue Neoplasms; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |
Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside.
Topics: Animals; Brain; Cell Hypoxia; Iodine Radioisotopes; Magnetic Resonance Spectroscopy; Male; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Photochemotherapy; Prostatic Neoplasms; Radionuclide Imaging; Rats; Tumor Cells, Cultured | 1993 |
Second generation hypoxia imaging agents.
Topics: Animals; Cell Hypoxia; Iodine Radioisotopes; Male; Nitroimidazoles; Oxygen; Photochemotherapy; Prostatic Neoplasms; Radionuclide Imaging; Rats | 1993 |
Prediction of tumour hypoxia and radioresistance with nuclear medicine markers.
Topics: Animals; Cell Hypoxia; Mice; Mice, SCID; Neoplasms, Experimental; Nitroimidazoles; Radiation Tolerance; Rats; Tomography, Emission-Computed, Single-Photon | 1996 |
Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside.
Topics: Cell Hypoxia; Humans; Neoplasms; Nitroimidazoles; Tomography, Emission-Computed, Single-Photon | 1996 |
Autoradiographic imaging of cerebral ischaemia using a combination of blood flow and hypoxic markers in an animal model.
Topics: Animals; Brain; Brain Ischemia; Cell Hypoxia; Cerebrovascular Circulation; Iodine Radioisotopes; Male; Nitroimidazoles; Organotechnetium Compounds; Oximes; Radionuclide Imaging; Rats; Rats, Wistar; Technetium Tc 99m Exametazime | 1997 |
The relationship between magnetic resonance diffusion imaging and autoradiographic markers of cerebral blood flow and hypoxia in an animal stroke model.
Topics: Animals; Autoradiography; Cell Hypoxia; Cerebrovascular Circulation; Cerebrovascular Disorders; Diffusion; Disease Models, Animal; Magnetic Resonance Imaging; Male; Nitroimidazoles; Rats; Rats, Wistar; Technetium Tc 99m Exametazime | 1999 |
Clinical pharmacokinetics of 123I-IAZA in healthy volunteers.
Topics: Adult; Female; Half-Life; Humans; Hypoxia; Iodine Radioisotopes; Male; Middle Aged; Models, Biological; Nitroimidazoles; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 1999 |
Identification of hypoxic regions in traumatic brain injury.
Topics: Brain Injuries; Humans; Hypoxia, Brain; Iodine Radioisotopes; Nitroimidazoles; Tomography, Emission-Computed, Single-Photon | 1999 |
Effects of methoxyflurane anesthesia on the pharmacokinetics of 125I-IAZA in Sprague-Dawley rats.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Area Under Curve; Biotransformation; Calibration; Chromatography, High Pressure Liquid; Half-Life; Iodine Radioisotopes; Isotope Labeling; Methoxyflurane; Nitroimidazoles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1999 |
Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinoside.
Topics: Animals; Injections, Intravenous; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Radionuclide Imaging; Tissue Distribution | 2000 |
Dosimetry estimations for 123I-IAZA in healthy volunteers.
Topics: Female; Gamma Cameras; Humans; Hypoxia; Iodine Radioisotopes; Male; Nitroimidazoles; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2001 |
Synthesis of 1-beta-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (beta-IAZA): a novel marker of tissue hypoxia.
Topics: Biomarkers; Cell Hypoxia; Nitroimidazoles; Stereoisomerism | 2003 |
A one-pot synthesis of 1-alpha- and 1-beta-D-arabinofuranosyl-2-nitroimidazoles: synthons to the markers of tumor hypoxia.
Topics: Biomarkers, Tumor; Cell Hypoxia; Molecular Structure; Monosaccharides; Neoplasms; Nitroimidazoles | 2005 |
[131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.
Topics: Animals; Cell Hypoxia; Cell Proliferation; Female; Humans; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Nitroimidazoles; Radioimmunotherapy; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Tetrazolium Salts; Thiazoles; Tissue Distribution; Tumor Cells, Cultured | 2005 |
Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors.
Topics: Cell Hypoxia; Cell Line, Tumor; Drug Design; Glucose Transport Proteins, Facilitative; Glucosides; Glycosides; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radionuclide Imaging; Radiopharmaceuticals; Transcriptional Activation | 2012 |
[131I]IAZA as a molecular radiotherapeutic (MRT) drug: wash-out with cold IAZA accelerates clearance in a murine tumor model.
Topics: Animals; Cold Temperature; Healthy Volunteers; Humans; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Radiopharmaceuticals; Tissue Distribution | 2013 |
Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Galactose; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanogels; Nitroimidazoles; Polyethylene Glycols; Polyethyleneimine; Radiation-Sensitizing Agents; Temperature; Theranostic Nanomedicine | 2015 |